Search Results

Your search matched 10 results

#1

In Patient Advocacy,“Grassroots” Means Meeting People Face to Face | In The Media

Learn about why it's still important to consider a human approach in healthcare communications from Jeanine O'Kane, President, Public Relations Group at inVentiv Health Communications.

#2

THE NEW PARTNERSHIP PARADIGM: WHAT PATIENT ADVOCATES SEEK FROM PHARMACEUTICAL PARTNERS | Perspectives

Dramatic changes in U.S. healthcare over the last few years have forced a rethinking of the partnerships pharmaceutical companies form with groups representing patients and families.

#3

PATIENT PARTNERS IN ONCOLOGY | Perspectives

Noticing important shifts in the rules of engagement between industry and patient advocates, Syneos Health Public Relations Group conducted in-depth interviews with dozens of patient organizations in early 2015.

#4

BETTER TOGETHER: STRENGTHENING ADVOCACY-INDUSTRY PARTNERSHIPS | Perspectives

Since the fall of 2015, and against a backdrop of harsh media attention to pharmaceutical pricing, patient advocacy groups that form partnerships with pharma companies have received negative coverage in The New York Times, USA Today and other publications.

#5

Modern Activism in Healthcare: A Guide for Preventing Your Advocates from Becoming Activists | Perspectives

Our PR Group is just back from Strengthening Patient Advocacy Relations Conference where Meg Alexander, Head, Reputation & Risk Management & Chris Iafolla, Head, Digital & Social Strategy, presented “Worlds Colliding: When Patient Activism Meets Pharma’s Digital Channels".

#6

SHARING THE MISSION TO CONQUER RARE DISEASES | Perspectives

At an ever-quickening pace, biopharmaceutical companies and patient advocacy groups are banding together to hasten development of new drugs for rare diseases.

#7

AN ADVOCACY RX FOR PROGRESS IN MENTAL HEALTH | Perspectives

As a source of human suffering, a barrier to workplace productivity, a burden on families and a driver of medical costs, mental illness amounts to an unparalleled public health crisis.

#8

Mental Health: An Insurance Industry Perspective | Perspectives

In more than 15 hours of interviews, executives at managed care organizations covering more than 59 million lives talked about issues that are top of mind for mental health patients, including medication access and psychiatric care.

#9

ADVANCING BEYOND PATIENT CENTRICITY: IDENTIFYING THE REAL-LIFE INFLUENCES OF HEALTH BEHAVIOR USING A SOCIAL-CENTRIC APPROACH | Perspectives

The pharmaceutical industry recognizes that consumer behavior is a key to both better individual health outcomes and greater business success, and has created a wide range of programs to engage and support patients who are taking prescribed medication.

#10

How payers and manufacturers can find common ground in rare diseases | Perspectives

Health insurers have raised challenging questions about how drugs for rare diseases are defined, regulated, and priced in the U.S. market.